DC Field
Value
Language
dc.contributor.author
Hofreither, Dominik
-
dc.contributor.author
Jahnel, Stefan
-
dc.contributor.author
Mendjan, Sasha
-
dc.contributor.author
Schittmayer-Schantl, Matthias
-
dc.contributor.author
Tomin, Tamara
-
dc.contributor.author
Birner-Grünberger, Ruth
-
dc.date.accessioned
2025-09-15T10:31:31Z
-
dc.date.available
2025-09-15T10:31:31Z
-
dc.date.issued
2025-05-11
-
dc.identifier.citation
<div class="csl-bib-body">
<div class="csl-entry">Hofreither, D., Jahnel, S., Mendjan, S., Schittmayer-Schantl, M., Tomin, T., & Birner-Grünberger, R. (2025, May 11). <i>Leveraging Mass Spectrometry-based Multiomics and advanced cardiac Organoid Models to investigate redox-metabolic Dysregulation in Ischemia-reperfusion Injury</i> [Poster Presentation]. ISHR 2025, Nara, Japan.</div>
</div>
-
dc.identifier.uri
http://hdl.handle.net/20.500.12708/219092
-
dc.description
https://www.ishr2025nara.jp/
-
dc.description.abstract
Introduction: Metabolic remodelling and oxidative stress are central contributors to heart disease progression, yet disentangling causative mechanisms from downstream effects remains challenging. Prior analyses on failing human hearts and murine tissue have implicated redox homeostasis as a key determinant of cardiac pathology, including the regulation of metabolic flux through enzymes such as pyruvate kinase M (PKM). Traditional models often lack physiological fidelity, limiting translational insights. Advanced cardiac organoids (cardioids) provide an in vitro platform that retains critical in vivo-like characteristics, enabling a more precise examination of redox-metabolic interactions in clinically relevant settings. Here, we present a metabolically matured cardioid system optimised to dissect ischemia-reperfusion injury (RI)-induced perturbations of the cellular metabolic and redox landscape.
Methods: To comprehensively investigate the interplay between aberrant metabolism and disturbed redox environments, a one-pot multiomics workflow integrating global proteomics, redox proteomics, and targeted redox metabolomics was employed. State-of-the-art mass spectrometry, combined with preservative two-step cysteine alkylation, enabled the precise assessment of glutathione redox status and its derivatives as proxies for cellular oxidative stress and antioxidant capacity. Additionally, capturing site-specific information of individual redox-sensitive (cysteine-containing) peptides provided high-resolution profiling of oxidative modifications, complementing proteomic analysis and offering more profound insights into redox-dependent signalling.
A novel human induced pluripotent stem cell (hiPSC)-derived cardiac organoid model was refined through a metabolic maturation protocol and subsequently characterised. The matured model was then subjected to normoxia, hypoxia, and ischemia-reperfusion conditions. To further elucidate the putative role of PKM, pharmacological activation via TEPP-46, a selective allosteric activator of PKM2, was concurrently incorporated into the experimental setup.
Results: The matured cardioid model exhibited enhanced (oxidative) metabolism, mitochondrial organisation and function, and structural fidelity, as indicated by changes in the cellular proteome and redox status, making it particularly suited for studying the intersection of metabolic dysfunction and redox imbalance in cardiac disease states. Building on this, we offer a comprehensive multiomics-based depiction of the model’s response in pathophysiologically relevant conditions, revealing distinct molecular signatures that differentiate ischemia-reperfusion from hypoxia-only conditions and highlighting unique vulnerabilities in RI.
Additionally, TEPP-46-mediated PKM2 activation under corresponding conditions provided further insights into its role as a key regulator of glycolytic flux and redox homeostasis, reinforcing previous findings in failing heart tissue.
Conclusions: This study establishes an optimised cardioid platform and mass spectrometry-based multiomics as a robust approach for investigating redox-regulated metabolic dysfunction in ischemia-reperfusion injury. Our findings support previously reported alterations in myocardial redox homeostasis in heart failure and identify redox-sensitive enzymes such as PKM as critical metabolic control nodes and potential therapeutic targets in cardiac stress responses. Furthermore, the ability to delineate RI-specific effects from hypoxia-driven changes further underscores the translational relevance of a systematic approach in modelling cardiac pathology and exploring targeted cardioprotective strategies.
en
dc.description.sponsorship
FWF - Österr. Wissenschaftsfonds
-
dc.description.sponsorship
FWF - Österr. Wissenschaftsfonds
-
dc.language.iso
en
-
dc.subject
multiomics
en
dc.subject
heart
en
dc.subject
ischemia
en
dc.title
Leveraging Mass Spectrometry-based Multiomics and advanced cardiac Organoid Models to investigate redox-metabolic Dysregulation in Ischemia-reperfusion Injury
en
dc.type
Presentation
en
dc.type
Vortrag
de
dc.contributor.affiliation
Institute of Molecular Biotechnology, Austria
-
dc.relation.grantno
F 7309-B21
-
dc.relation.grantno
FG 1200-N
-
dc.type.category
Poster Presentation
-
tuw.project.title
Lipidhydrolyse im Krebs und in Lipid-assoziierten Krankheiten
-
tuw.project.title
Digitalized Production of Therapeutics
-
tuw.researchinfrastructure
Cell Culture Core Facility (CCCF)
-
tuw.researchTopic.id
X1
-
tuw.researchTopic.name
Beyond TUW-research focus
-
tuw.researchTopic.value
100
-
tuw.publication.orgunit
E164-01-3 - Forschungsgruppe Bioanalytik
-
tuw.publication.orgunit
E056-12 - Fachbereich ENROL DP
-
tuw.author.orcid
0000-0003-1147-9179
-
tuw.author.orcid
0000-0001-7539-3951
-
tuw.author.orcid
0000-0003-3249-655X
-
tuw.author.orcid
0000-0002-7071-2316
-
tuw.author.orcid
0000-0003-3950-0312
-
tuw.event.name
ISHR 2025
en
tuw.event.startdate
11-05-2025
-
tuw.event.enddate
14-05-2025
-
tuw.event.online
On Site
-
tuw.event.type
Event for scientific audience
-
tuw.event.place
Nara
-
tuw.event.country
JP
-
tuw.event.institution
International society for Heart Research
-
tuw.event.presenter
Hofreither, Dominik
-
wb.sciencebranch
Chemie
-
wb.sciencebranch
Biologie
-
wb.sciencebranch
Anatomie, Pathologie, Physiologie
-
wb.sciencebranch.oefos
1040
-
wb.sciencebranch.oefos
1060
-
wb.sciencebranch.oefos
3011
-
wb.sciencebranch.value
50
-
wb.sciencebranch.value
25
-
wb.sciencebranch.value
25
-
item.languageiso639-1
en
-
item.openairetype
conference poster not in proceedings
-
item.openairecristype
http://purl.org/coar/resource_type/c_18co
-
item.grantfulltext
none
-
item.cerifentitytype
Publications
-
item.fulltext
no Fulltext
-
crisitem.author.dept
E164-01-3 - Forschungsgruppe Bioanalytik
-
crisitem.author.dept
Institute of Molecular Biotechnology, Austria
-
crisitem.author.dept
E164-01-3 - Forschungsgruppe Bioanalytik
-
crisitem.author.dept
E164-01-3 - Forschungsgruppe Bioanalytik
-
crisitem.author.dept
E164-01 - Forschungsbereich Imaging und Instrumentelle Analytische Chemie
-
crisitem.author.orcid
0000-0003-1147-9179
-
crisitem.author.orcid
0000-0001-7539-3951
-
crisitem.author.orcid
0000-0003-3249-655X
-
crisitem.author.orcid
0000-0002-7071-2316
-
crisitem.author.orcid
0000-0003-3950-0312
-
crisitem.author.parentorg
E164-01 - Forschungsbereich Imaging und Instrumentelle Analytische Chemie
-
crisitem.author.parentorg
E164-01 - Forschungsbereich Imaging und Instrumentelle Analytische Chemie
-
crisitem.author.parentorg
E164-01 - Forschungsbereich Imaging und Instrumentelle Analytische Chemie
-
crisitem.author.parentorg
E164 - Institut für Chemische Technologien und Analytik
-
crisitem.project.funder
FWF - Österr. Wissenschaftsfonds
-
crisitem.project.funder
FWF - Österr. Wissenschaftsfonds
-
crisitem.project.grantno
F 7309-B21
-
crisitem.project.grantno
FG 1200-N
-
Appears in Collections: